Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX).
- Disclosed ownership: 7.3%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 7.3% ownership in Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 7% | 1,465,105 | 0 | 1,465,105 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 7% | 1,465,105 | 0 | 1,465,105 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Biotech Private Investments, LLC | 0.3% | 65,933 | 0 | 65,933 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| Differentiated Ventures Investments, LLC | 0.3% | 65,933 | 0 | 65,933 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| 72 Investment Holdings, LLC | 0.3% | 65,933 | 0 | 65,933 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 7.3% | 1,531,038 | 0 | 1,531,038 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |